Vivani Medical (VANI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.12, -2.61% vs the prior close of $1.15.
- Volume 361.57K shares, 1.8x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
VANI dips 2.6% to $1.12, a 3-month low on 1.8x normal volume. Closed at $1.12, -2.61% vs the prior close of $1.15. Day range $1.10–$1.16, opened at $1.15.
VANI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — VANI dips 2.6% to $1.12, a 3-month low on 1.8x normal volume
- Closed at $1.12, -2.61% vs the prior close of $1.15. Day range $1.10–$1.16, opened at $1.15.
- Volume was 361.57K shares, 1.8x its 50-day average of 200.83K — unusually heavy trading.
- Price is -13.9% vs its 50-day average ($1.30) and -11.4% vs its 200-day average ($1.26).
- 52-week range $0.92–$1.92; today's close sits at 20% of that range, 41.7% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — VANI dips 0.9% to $1.15, a 3-month low, 4 down days in a row
- Closed at $1.15, -0.86% vs the prior close of $1.16. Day range $1.15–$1.17, opened at $1.15.
- Volume was 108.40K shares, 0.5x its 50-day average of 200.42K — lighter than usual.
- Price is -12.0% vs its 50-day average ($1.31) and -9.1% vs its 200-day average ($1.26).
- 52-week range $0.92–$1.92; today's close sits at 23% of that range, 40.1% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — VANI dips 1.7% to $1.16, a 3-month low, 3 down days in a row
- Closed at $1.16, -1.69% vs the prior close of $1.18. Day range $1.16–$1.19, opened at $1.17.
- Volume was 157.10K shares, 0.8x its 50-day average of 200.42K.
- Price is -11.5% vs its 50-day average ($1.31) and -8.3% vs its 200-day average ($1.27).
- 52-week range $0.92–$1.92; today's close sits at 24% of that range, 39.6% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — VANI dips 0.8% to $1.18, a 3-month low
- Closed at $1.18, -0.84% vs the prior close of $1.19. Day range $1.16–$1.19, opened at $1.19.
- Volume was 269.10K shares, 1.4x its 50-day average of 197.96K.
- Price is -10.3% vs its 50-day average ($1.32) and -6.8% vs its 200-day average ($1.27).
- 52-week range $0.92–$1.92; today's close sits at 26% of that range, 38.5% below the 52-week high.
Oct 12, 2026 — VANI slides 4.8% to $1.19
- Closed at $1.19, -4.80% vs the prior close of $1.25. Day range $1.19–$1.23, opened at $1.22.
- Volume was 146.50K shares, 0.7x its 50-day average of 195.72K.
- Price is -9.8% vs its 50-day average ($1.32) and -6.1% vs its 200-day average ($1.27).
- 52-week range $0.92–$1.92; today's close sits at 27% of that range, 38.0% below the 52-week high.
Oct 9, 2026 — VANI rises 1.6% to $1.25
- Closed at $1.25, +1.63% vs the prior close of $1.23. Day range $1.21–$1.25, opened at $1.22.
- Volume was 101.90K shares, 0.5x its 50-day average of 195.47K — lighter than usual.
- Price is -5.3% vs its 50-day average ($1.32) and -1.4% vs its 200-day average ($1.27).
- 52-week range $0.92–$1.92; today's close sits at 33% of that range, 34.9% below the 52-week high.
Oct 8, 2026 — VANI slides 3.1% to $1.23
- Closed at $1.23, -3.15% vs the prior close of $1.27. Day range $1.19–$1.31, opened at $1.26.
- Volume was 260.70K shares, 1.4x its 50-day average of 191.95K.
- Price is -6.9% vs its 50-day average ($1.32) and -3.0% vs its 200-day average ($1.27).
- 52-week range $0.92–$1.92; today's close sits at 31% of that range, 35.9% below the 52-week high.
Oct 7, 2026 — VANI rises 2.4% to $1.27
- Closed at $1.27, +2.42% vs the prior close of $1.24. Day range $1.24–$1.34, opened at $1.25.
- Volume was 272.40K shares, 1.4x its 50-day average of 190.87K.
- Price is -3.9% vs its 50-day average ($1.32) and +0.1% vs its 200-day average ($1.27).
- 52-week range $0.92–$1.92; today's close sits at 35% of that range, 33.9% below the 52-week high.
Oct 6, 2026 — VANI rises 1.6% to $1.24
- Closed at $1.24, +1.64% vs the prior close of $1.22. Day range $1.22–$1.26, opened at $1.24.
- Volume was 100.60K shares, 0.5x its 50-day average of 191.54K — lighter than usual.
- Price is -6.3% vs its 50-day average ($1.32) and -2.4% vs its 200-day average ($1.27).
- 52-week range $0.92–$1.92; today's close sits at 32% of that range, 35.4% below the 52-week high.
Oct 5, 2026 — VANI dips 0.8% to $1.22
- Closed at $1.22, -0.81% vs the prior close of $1.23. Day range $1.22–$1.25, opened at $1.22.
- Volume was 95.20K shares, 0.5x its 50-day average of 193.70K — lighter than usual.
- Price is -7.9% vs its 50-day average ($1.32) and -4.0% vs its 200-day average ($1.27).
- 52-week range $0.92–$1.92; today's close sits at 30% of that range, 36.5% below the 52-week high.
Oct 2, 2026 — VANI rises 0.8% to $1.23
- Closed at $1.23, +0.82% vs the prior close of $1.22. Day range $1.23–$1.25, opened at $1.25.
- Volume was 88.20K shares, 0.4x its 50-day average of 196.01K — lighter than usual.
- Price is -7.2% vs its 50-day average ($1.33) and -3.3% vs its 200-day average ($1.27).
- 52-week range $0.92–$1.92; today's close sits at 31% of that range, 35.9% below the 52-week high.
VANI latest news & SEC filings
Every SEC filing by or about VANI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 25, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$6.37M (prior year -$7.14M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.07 (prior year -$0.12) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade VANI
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 26, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.83% (largest 4.8%).
- Liquidity: about 149.93K shares (≈$167.93K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.12 vs a range of $0.92–$1.92 (20% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Gregg Williams bought 793,650 shares on Jul 15, 2026.
- Latest filings: 8-K Sep 16, 2026; 8-K Aug 17, 2026; 8-K Aug 13, 2026.
- Share count: 90.20M shares outstanding (Aug 13, 2026), +52.3% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Electromedical & Electrotherapeutic Apparatus.
VANI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.15 | 1.16 | 1.10 | 1.12 | 361.57K |
| Oct 15, 2026 | 1.15 | 1.17 | 1.15 | 1.15 | 108.40K |
| Oct 14, 2026 | 1.17 | 1.19 | 1.16 | 1.16 | 157.10K |
| Oct 13, 2026 | 1.19 | 1.19 | 1.16 | 1.18 | 269.10K |
| Oct 12, 2026 | 1.22 | 1.23 | 1.19 | 1.19 | 146.50K |
| Oct 9, 2026 | 1.22 | 1.25 | 1.21 | 1.25 | 101.90K |
| Oct 8, 2026 | 1.26 | 1.31 | 1.19 | 1.23 | 260.70K |
| Oct 7, 2026 | 1.25 | 1.34 | 1.24 | 1.27 | 272.40K |
| Oct 6, 2026 | 1.24 | 1.26 | 1.22 | 1.24 | 100.60K |
| Oct 5, 2026 | 1.22 | 1.25 | 1.22 | 1.22 | 95.20K |
| Oct 2, 2026 | 1.25 | 1.25 | 1.23 | 1.23 | 88.20K |
| Oct 1, 2026 | 1.23 | 1.26 | 1.22 | 1.22 | 63.80K |
| Sep 30, 2026 | 1.24 | 1.27 | 1.24 | 1.24 | 119.10K |
| Sep 29, 2026 | 1.25 | 1.25 | 1.22 | 1.23 | 82.90K |
| Sep 28, 2026 | 1.24 | 1.27 | 1.23 | 1.25 | 107.00K |
| Sep 25, 2026 | 1.25 | 1.26 | 1.23 | 1.24 | 128.20K |
| Sep 24, 2026 | 1.23 | 1.24 | 1.22 | 1.23 | 80.20K |
| Sep 23, 2026 | 1.26 | 1.27 | 1.21 | 1.23 | 149.10K |
| Sep 22, 2026 | 1.24 | 1.31 | 1.24 | 1.27 | 174.90K |
| Sep 21, 2026 | 1.20 | 1.27 | 1.20 | 1.24 | 131.80K |
About Vivani Medical
Vivani Medical (VANI) is listed on the Nasdaq and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in ALAMEDA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1266806.
VANI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Daniel Bradbury | Director | Jul 28, 2026 |
| Aaron Mendelsohn | Director | Jun 25, 2026 |
| Adam Mendelsohn | Chief Executive Officer | Jul 30, 2026 |
| August J Moretti | Director | Jun 26, 2026 |
| Alexandra L. Popoff | Director | Jun 25, 2026 |
| Gregg Williams | Director | Jul 16, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Anthony Baldor | Chief Financial Officer | Jul 30, 2026 |
| Donald Dwyer | Chief Business Officer | Jul 30, 2026 |
| Truc Le | Chief Operations Officer | Jul 30, 2026 |
| Adam Mendelsohn | Chief Executive Officer | Jul 30, 2026 |
| Lisa Ellen Porter | Chief Medical Officer | Jul 30, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 15, 2026 | Gregg Williams | Buy | 793,650 | $1.26 |
| Jul 15, 2026 | Gregg Williams | Buy | 793,650 | $1.26 |
| Jul 15, 2026 | Gregg Williams | Buy | 793,650 | $1.26 |
| Jul 15, 2026 | Gregg Williams | Buy | 793,650 | $1.26 |
| Jun 15, 2026 | Gregg Williams | Buy | 1,587,301 | $1.26 |
| Jun 15, 2026 | Gregg Williams | Buy | 1,587,301 | $1.26 |
| Jun 15, 2026 | Gregg Williams | Buy | 1,587,301 | $1.26 |
| Jun 15, 2026 | Gregg Williams | Buy | 1,587,301 | $1.26 |
| May 15, 2026 | Gregg Williams | Buy | 1,587,301 | $1.26 |
| May 15, 2026 | Gregg Williams | Buy | 1,587,301 | $1.26 |
| May 15, 2026 | Gregg Williams | Buy | 1,587,301 | $1.26 |
| May 15, 2026 | Gregg Williams | Buy | 1,587,301 | $1.26 |
| Apr 15, 2026 | Gregg Williams | Buy | 1,587,301 | $1.26 |
| Apr 15, 2026 | Gregg Williams | Buy | 1,587,301 | $1.26 |
| Apr 15, 2026 | Gregg Williams | Buy | 1,587,301 | $1.26 |
VANI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-26.61M | -0.43 | $-24.32M |
| Dec 31, 2024 | — | $-23.49M | -0.43 | $-20.79M |
| Dec 31, 2023 | — | $-25.65M | -0.50 | $-23.70M |
| Dec 31, 2022 | — | $-13.89M | — | $-18.79M |
| Dec 31, 2021 | — | $-12.77M | — | $-10.95M |
Latest balance sheet: total assets $41.64M, total liabilities $22.67M, cash $19.89M (as of Jun 30, 2026).
VANI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $1.34 |
| May 13, 2026 | 8-K Item 2.02 (results) | $1.16 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $1.08 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $1.36 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $1.26 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $1.50 |
| May 13, 2025 | 8-K Item 2.02 (results) | $1.05 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $1.05 |
| Mar 13, 2025 | 8-K Item 2.02 (results) | $1.06 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $1.39 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)Integer (ITGR)TransMedics (TMDX)Axogen (AXGN)LivaNova (LIVN)Nexalin Technology (NXL)Conmed (CNMD)Ceribell (CBLL)InMode (INMD)Electromed (ELMD)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on VANI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.